B

Beeline Medicines

Clinical-stage biotech developing precision autoimmune therapies

Medical Science Liaison / Senior Medical Science Liaison

Clinical Research OperationsUpdated on Nov 10
Full-timeIndiaNo salary listed

About the Job

Requirements

  • An advanced PharmD, PhD, or MD in a relevant life sciences, pharmacy, or biomedical field is required; post-doctoral training, clinical fellowship, or residency in a relevant discipline is strongly preferred.
  • The Medical Science Liaison role requires at least 3 years of MSL or related field-based medical affairs experience in pharmaceutical or biotech, preferably in immunology, inflammation, or a related therapeutic area. Clinical-stage biotech experience is a plus.
  • The Senior Medical Science Liaison role requires at least 5 years of MSL or field-based medical affairs experience in pharmaceutical or biotech, preferably with demonstrated expertise in immunology, inflammation, or a closely related therapeutic area. Prior involvement in investigator-initiated study management or clinical-trial support is preferred; clinical-stage biotech experience is a plus.
  • The MSL must demonstrate developing scientific and clinical knowledge of immunology and inflammation, including disease mechanisms, treatment landscapes, and emerging therapies, and be building expertise through ongoing learning.
  • The MSL must interpret and communicate clinical and scientific data, including study design, statistical concepts, and benefit-risk assessment, in peer-to-peer settings with healthcare professionals, key medical experts, and investigators.
  • The MSL must have working proficiency in customer relationship management platforms such as Veeva for field documentation, stakeholder mapping, and territory management, and develop consistent compliant documentation habits.
  • The MSL must build knowledge of medical affairs compliance, including FDA and EMA regulations, PhRMA guidelines, and on-label versus off-label scientific exchange, and demonstrate compliant field behavior.
  • The MSL must develop independence in managing territory priorities, engagement calendars, and field activities with increasing self-direction, and contribute actively to team discussions and learning.
  • The MSL must develop scientific communication skills to present and discuss immunology and inflammation data clearly and accurately, capture field insights and clinical-practice observations, and communicate them concisely internally.
  • The MSL must develop effectiveness in one-on-one and small-group scientific meetings and conference interactions, with growth toward advisory-board and large-group facilitation.
  • The Senior MSL must demonstrate advanced scientific and clinical expertise in immunology and inflammation, including disease biology, treatment algorithms, trial endpoints, emerging mechanisms, and the competitive landscape.
  • The Senior MSL must interpret, contextualize, and communicate complex clinical and translational data, including study-design nuances, subgroup analyses, and evolving safety and efficacy profiles, in discussions with senior key opinion leaders and investigators.
  • The Senior MSL must be proficient in Veeva CRM and medical-affairs field tools, with experience in digital engagement platforms and virtual scientific exchange and consistent high-quality documentation.
  • The Senior MSL must leverage AI-driven and omnichannel engagement strategies to complement in-person interactions and optimize stakeholder reach, frequency, and scientific-exchange effectiveness.
  • The Senior MSL must have deep working knowledge of medical-affairs compliance, including PhRMA guidelines, FDA regulations, and investigator-initiated study management frameworks, and be able to guide junior colleagues on compliance questions.
  • The Senior MSL must operate independently in territory management and engagement planning, identify opportunities, address challenges, and use sound judgment and organizational awareness.
  • The Senior MSL must communicate complex scientific information effectively to senior key opinion leaders, principal investigators, and academic thought leaders, and present structured, executive-ready field intelligence and actionable recommendations.
  • The Senior MSL must be experienced in one-on-one key opinion leader settings, investigator meetings, advisory boards, and large medical congresses, adapting scientific communication to the audience.
  • Professional fluency in English, written and verbal, is required for both levels.
  • Both levels require the ability to operate a motor vehicle safely, a valid driver's license, and a driving record meeting company standards.
  • Both levels may require travel of 50% or more, including occasional overnight stays, and evening and weekend work for physician or patient events.
  • Depending on geography, both levels require the ability to manage a multi-state territory with a diverse customer base.

Responsibilities

  • Contribute to development and refinement of medical strategy through field insights and engagement with healthcare professionals, key medical experts, and investigators.
  • Develop and execute territory plans aligned with organizational priorities and data milestones.
  • Develop and manage territory relationships with key medical experts, healthcare professionals, clinical investigators, and academic centers relevant to the pipeline, identifying, mapping, and engaging scientific thought leaders under Medical Affairs leadership.
  • Lead stakeholder segmentation, strategic engagement planning, and longitudinal relationship ownership.
  • Conduct peer-to-peer scientific exchange, sharing clinical and preclinical data, presenting pipeline updates, and discussing unmet medical needs in immunology and inflammation in a balanced and compliant manner.
  • Support clinical-trial awareness and site identification by engaging potential investigators and academic institutions; serve as a scientific-exchange resource for site investigators from site startup through study closeout in collaboration with Clinical Operations.
  • Respond accurately and promptly to unsolicited medical-information requests in partnership with Medical Information and in accordance with regulatory and compliance guidelines.
  • Support investigator-initiated study processes through scientific discussions and coordination with Medical Affairs leadership.
  • Identify evidence gaps and contribute to evidence-generation strategies.
  • Generate, synthesize, and translate key medical expert perspectives, competitive intelligence, clinical-practice trends, and unmet-need observations into timely, structured recommendations for Medical Affairs, Clinical Development, and cross-functional teams.
  • Represent the company at scientific conferences, medical congresses, and advisory-board meetings, engaging scientific thought leaders and gathering information to inform medical and pipeline strategy.
  • For the Senior MSL, lead and manage a strategically defined territory of senior key opinion leaders, investigators, and academic centers; develop long-term individualized engagement plans and refine territory strategy based on data milestones, influence mapping, and clinical-development priorities.
  • For the Senior MSL, conduct advanced peer-to-peer scientific exchange on emerging clinical data, benefit-risk considerations, and evolving disease paradigms.
  • For the Senior MSL, provide senior field support for clinical trials, including investigator identification, scientific site engagement, and contributions to enrollment-strategy discussions with Clinical Development and Clinical Operations.
  • For the Senior MSL, own investigator-initiated study relationships, serve as the primary scientific contact for investigators, facilitate review processes, and maintain scientific engagement with funded study sites.
  • For the Senior MSL, synthesize and present strategic stakeholder insights and field intelligence to inform organizational decisions, and demonstrate impact on Medical Affairs priorities, trial enrollment, site activation, and strategic decisions.
  • For the Senior MSL, contribute to scientific training materials, field tools, and disease-area resources to strengthen MSL team capabilities and effectiveness.
  • For the Senior MSL, represent the company at major national and international conferences, advisory boards, and key opinion leader forums; contribute to advisory-board development and execution, including expert identification, agenda input, and synthesis of outcomes into strategic recommendations.
  • Perform other duties and responsibilities as assigned.

Desired Qualifications

  • Post-doctoral training, clinical fellowship, or residency in a relevant discipline is strongly preferred.
  • For the MSL role, experience in immunology, inflammation, or a related therapeutic area is strongly preferred; clinical-stage biotech experience is a plus.
  • For the Senior MSL role, demonstrated expertise in immunology, inflammation, or a closely related therapeutic area is preferred; prior investigator-initiated study management or clinical-trial support experience is preferred, and clinical-stage biotech experience is a plus.

About the Company

Beeline Medicines

Clinical-stage biotech developing precision autoimmune therapies

Beeline Medicines focuses on precision therapies for autoimmune and inflammatory diseases, advancing a portfolio of in-licensed programs from Bristol Myers Squibb with strong backing from Bain Capital. Its lead, afimetoran, is an oral TLR7/8 inhibitor for lupus, with lomedeucitinib as an allosteric TYK2 inhibitor and two IND-stage biologics targeting IL-18 and IL-10 pathways to modulate immune signaling. The company differentiates itself by combining externally sourced programs with a leadership team experienced in drug development and commercialization, pursuing multiple mechanism-driven candidates rather than a single modality, supported by substantial early funding. Its goal is to move its clinical-stage therapies toward pivotal trials and bring targeted immune-modulating treatments to patients, beginning with completing Phase 2 for afimetoran in late 2026 and following with a pivotal program.

Company size
51-200
Company stage
Series A
Total funding
$426.3M
Headquarters
Stamford, CT
Founded
2025

Recently Posted Jobs

Explore more opportunities at Beeline Medicines

See more jobs